Pharmacological Treatments for Premature Ejaculation

Use of Topical Anesthetics in the Management of Premature Ejaculation

The pharmacological approach to premature ejaculation aims to increase intravaginal latency time by reducing penile sensitivity or modulating neurochemical pathways.

Topical anesthetics are among the options for local application. These creams or sprays desensitize the surface of the glans to delay the activation of the ejaculatory reflex in response to tactile stimulation.

Although their use has been common on an empirical basis, clinical eva luation reveals limitations such as the potential for excessive loss of sensitivity or hypoesthesia in men, as well as the unintentional transfer of the active ingredient to the partner if barrier methods are not used.

For this reason, modern clinical sexology prioritizes interventions with greater specificity and predictability in their response.

Use of Selective Serotonin Reuptake Inhibitors

Selective serotonin reuptake inhibitors, known as SSRIs, revolutionized pharmacological therapy when it was observed that delayed ejaculation was a consistent side effect of their mechanism of action. Serotonin acts at the supraspinal level by inhibiting the modulation of the ejaculatory reflex.

Traditional drugs in this class, when administered continuously, have proven effective in prolonging latency. However, their daily use can lead to tolerance or systemic adverse effects.

Sexological research has determined that serotonergic modulation must be tailored to the patient’s individual needs, taking into account both the functional benefits in terms of control and the impact on the individual’s quality of life and well-being during sexual activity.

Characteristics and Dosage of On-Demand Dapoxetine

Dapoxetine is the first drug in the SSRI class designed and approved specifically for the treatment of premature ejaculation.

Unlike conventional antidepressants, dapoxetine is characterized by rapid absorption and accelerated elimination, allowing it to be administered on an as-needed basis rather than continuously.

The recommended dosage is 30 milligrams, taken one to three hours before anticipated sexual activity.

By acting rapidly on the central nervous system, it enhances voluntary control over ejaculation without causing a prolonged accumulation of the drug in the body.

This on-demand strategy optimizes treatment adherence, reduces performance anxiety, and significantly reduces negative emotional repercussions for the partner.

Integrating the Pharmacological Approach into Clinical Sexology

The use of psychotropic medications in the treatment of premature ejaculation requires a precise eva luation by a specialist.